A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together

NCT00618124 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Breast Cancer
Neoplasms

Interventions

DRUG: SU011248; Capecitabine

Sponsor

Pfizer